MiMedx Group, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- MiMedx Group, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-12-31 was -$1.00K, a 100.17% decline year-over-year.
- MiMedx Group, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-09-30 was $387.00K, a 0.26% increase year-over-year.
- MiMedx Group, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $244.00K, a 1120.00% increase year-over-year.
- MiMedx Group, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-03-31 was $766.00K.
- MiMedx Group, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $1.40M, a 40.12% increase from fiscal 2023.
- MiMedx Group, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $997.00K, a 53.15% increase from fiscal 2022.
- MiMedx Group, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $651.00K, a 54.70% decline from fiscal 2021.
- MiMedx Group, Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $1.44M, a 249.64% increase from fiscal 2020.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2024-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.40M 10-K · filed 2026-02-25 |
| 2024-09-30 | $387.00K 10-Q · filed 2025-10-29 | $1.99M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $244.00K 10-Q · filed 2025-07-30 | $1.99M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $766.00K 10-Q · filed 2025-04-30 | $1.76M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $591.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $997.00K 10-K · filed 2026-02-25 |
| 2023-09-30 | $386.00K 10-Q · filed 2024-10-30 | |
| 2023-06-30 | $20.00K 10-Q · filed 2024-07-31 | |
| 2022-12-31 | $77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $651.00K 10-K · filed 2025-02-26 |
| 2022-09-30 | $137.00K 10-Q · filed 2023-10-30 | $607.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $271.00K 10-Q · filed 2023-08-01 | $515.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $166.00K 10-Q · filed 2023-05-02 | $688.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $1.44M 10-K · filed 2024-02-28 |
| 2021-09-30 | $45.00K 10-Q · filed 2022-11-02 | $1.45M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $444.00K 10-Q · filed 2022-08-02 | $1.47M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $915.00K 10-Q · filed 2022-05-03 | $1.03M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $411.00K 10-K · filed 2023-02-28 |
| 2020-09-30 | $72.00K 10-Q · filed 2021-11-02 | $370.00K derived: sum of 4 quarters · filed 2021-11-02 |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-03 | $298.00K derived: sum of 4 quarters · filed 2021-08-03 |
| 2020-03-31 | $298.00K 10-Q · filed 2021-04-28 | $406.00K derived: sum of 4 quarters · filed 2021-04-28 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $108.00K 10-K · filed 2021-03-08 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | |
| 2019-06-30 | $108.00K 10-Q · filed 2020-08-04 | |
| 2018-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $3.56M 10-K · filed 2021-03-08 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-07-06 | $3.95M derived: sum of 4 quarters · filed 2020-07-06 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-06 | $6.35M derived: sum of 4 quarters · filed 2020-07-06 |
| 2018-03-31 | $3.55M 10-Q · filed 2020-07-06 | $13.68M derived: sum of 4 quarters · filed 2020-07-06 |
| 2017-12-31 | $397.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-06 | $11.99M 10-K · filed 2020-07-06 |
| 2017-09-30 | $2.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $12.54M derived: sum of 4 quarters · filed 2020-03-17 |
| 2017-06-30 | $7.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | $10.67M derived: sum of 4 quarters · filed 2020-03-17 |
| 2017-03-31 | $1.86M 10-Q · filed 2017-05-01 | $4.22M derived: sum of 4 quarters · filed 2020-03-17 |
| 2016-12-31 | $946.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | $3.49M 10-K · filed 2020-03-17 |
| 2016-09-30 | $532.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $3.71M derived: sum of 4 quarters · filed 2017-03-01 |
| 2016-06-30 | $878.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | $3.90M derived: sum of 4 quarters · filed 2017-03-01 |
| 2016-03-31 | $1.14M 10-Q · filed 2016-05-10 | $4.49M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-12-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $4.63M 10-K · filed 2017-03-01 |
| 2015-09-30 | $724.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $4.44M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $1.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $4.33M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $1.28M 10-Q · filed 2015-05-01 | $3.30M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $972.91K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $2.47M 10-K · filed 2017-03-01 |
| 2014-09-30 | $614.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $1.96M derived: sum of 4 quarters · filed 2017-02-22 |
| 2014-06-30 | $437.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $2.32M derived: sum of 4 quarters · filed 2017-02-22 |
| 2014-03-31 | $445.07K 10-Q · filed 2014-05-12 | $2.19M derived: sum of 4 quarters · filed 2017-02-22 |
| 2013-12-31 | $464.42K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | $1.98M 10-K · filed 2017-02-22 |
| 2013-09-30 | $973.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $1.68M derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-06-30 | $310.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $1.28M derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-03-31 | $232.53K 10-Q · filed 2013-05-10 | $1.11M derived: sum of 4 quarters · filed 2015-03-13 |
| 2012-12-31 | $167.97K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $1.05M 10-K · filed 2015-03-13 |
| 2012-09-30 | $569.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | $885.03K derived: sum of 4 quarters · filed 2014-03-04 |
| 2012-06-30 | $144.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $611.04K derived: sum of 4 quarters · filed 2014-03-04 |
| 2012-03-31 | $171.00K 10-Q · filed 2012-05-14 | |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-04 | $295.75K 10-K · filed 2014-03-04 |
| 2011-09-30 | $295.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | |
| 2010-12-31 | $155.13K 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |